PD-MitoQUANT Principal Investigators organise conference on the pathophysiology of Parkinson’s disease
Prinicpal Investigators of the Innovative Medicines Initative’s PD-MitoQUANT project Olga Corti, Stéphane Hunot (both based
Sin categoría
Alzheimer Europe Lunch Debate focusses on improving the diagnosis of dementia
On 10 December, two Innovative Medicines Initiative projects participated in an Alzheimer Europe Lunch Debate.
Spotlight on early-career researchers: a Neuronet interview with Lianne Reus
Interview with Lianne Reus, PhD candidate at Amsterdam UMC focusing on social withdrawal in schizophrenia, depression and the early stage of AD.
Spotlight on EPAD study site Fundació ACE
The team of Dr. Mercè Boada began recruiting in June 2019 and has currently recruited over 60 participants in the EPAD Longitudinal Cohort Study.
EPAD V1500.0 dataset is now available for EPAD researchers
The Innovative Medicines Initiative‘s EPAD (European Prevention of Alzheimer’s Dementia Consortium) announced the internal release
Highlights of PD-MitoQUANT Plenary Meeting
At the sunny coastal town of Herzeliya, Israel, over 35 participants from 8 countries across
The European Prevention of Alzheimer’s Dementia Consortium releases its first wave of data
The European Prevention of Alzheimer’s Dementia (EPAD), a major Europe-wide initiative aiming to improve the
Spotlight on early-career investigators: an interview with Benjamin Falcon
Dr Benjamin Falcon is a postdoctoral scientist at the UK Medical Research Council Laboratory of
Neuronet meeting focuses on key assets and collaborations of IMI neurodegeneration projects
On 20 November (Madrid, Spain), Neuronet held a team meeting on key assets with representatives
AETIONOMY results presented to Innovative Medicines Initative leadership
AETIONOMY started five years ago exploring the idea that conventional disease definition is an increasingly outdated concept in the medical environment.